INSIGHTS ON DRUG DEVELOPMENT

• Overcoming Volume And Viscosity Barriers In Biologic Formulations

  Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.

• Comprehensive GMP Testing Services

  Eurofins delivers global GMP testing with 45+ facilities, ensuring regulatory acceptance, quality, and trusted service from starting materials to finished products.

• Spray Dried Biologics For Injectable Dosage Forms

  Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

• NGS Identification Of Internal Tandem Duplications In FLT3

  Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.

• Solving Bioavailability Challenges In bRo5 Drugs

  3/20/2026

  Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

• How The Accelerator™ Drug Development Model Enhances eNPV

  2/25/2026

  Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

• Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development

  3/2/2026

  Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.

• How Biocatalysts Address Process Development Issues

  7/23/2026

  Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.

• Aggregate Analysis Of Tirzepatide

  12/11/2025

  A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.